잠시만 기다려 주세요. 로딩중입니다.

Feasibility and Safety of Single-Port Video-Assisted Thoracic Surgery for Primary Lung Cancer

대한흉부외과학회지
2017년 50권 3호 p.190 ~ p.196
 ( Heo Woon ) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery

강도균 ( Kang Do-Kyun ) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
 ( Min Ho-Ki ) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
전희재 ( Jun Hee-Jae ) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery
황윤호 ( Hwang Youn-Ho ) - Inje University College of Medicine Haeundae Paik Hospital Department of Thoracic and Cardiovascular Surgery

Abstract

Background: The feasibility of single-port video-assisted thoracic surgery (SPVATS) for primary lung cancer is not well understood. In this study, we compared SP and multi-port (MP) VATS for the surgical treatment of patients with primary lung cancer.

Methods: Surgical treatment was performed in 181 patients with primary lung cancer at Inje University Haeundae Paik Hospital between June 2012 and December 2015. A propensity-matched analysis was used to compare the postoperative outcomes and to evaluate the comparative feasibility and safety of SPVATS and MPVATS.

Results: There were 37 patients in the SPVATS group and 67 patients in the MPVATS group. Propensity matching produced 32 pairs. The operation time (210 minutes versus 200 minutes, p=0.11), volume of the estimated blood loss (170 mL versus 160 mL, p=0.19), duration of chest tube drainage (5 days versus 6 days, p=0.66), and length of hospital stay (9 days versus 10 days, p=0.89) were similar between the 2 groups.

Conclusion: In our study, SPVATS for primary lung cancer was safe and feasible in well selected patients. A prospective, randomized study with a large group and long-term follow-up is necessary to evaluate the clinical feasibility and the advantages of SPVATS for primary lung cancer.

키워드

원문 및 링크아웃 정보
  
등재저널 정보
학술진흥재단(KCI) KoreaMed 대한의학회 회원 
주제코드
주제명
(Target field)
연구대상
(Population)
연구참여
(Sample size)
대상성별
(Gender)
질병특성
(Condition Category)
연구환경
(Setting)
연구설계
(Study Design)
연구기간
(Period)
중재방법
(Intervention Type)
중재명칭
(Intervention Name)
키워드
(Keyword)
유효성결과
(Recomendation)
연구비지원
(Fund Source)
근거수준평가
(Evidence Hierarchy)
출판년도
(Year)
참여저자수
(Authors)
대표저자
(1st Authors)
Doi
KCD코드
ICD 03
건강보험코드